Watch this Space!

We will be announcing more exciting presentations soon...

Conference Opening Times:


14 March: 08:00 - 19:30  |  15 March: 08:00 - 17:45


Session Titles

Bioinformatic Challenges in Microbiome Analyses
Regulatory Affairs
Identifying Biomarkers

Bioinformatic Challenges in Microbiome Analyses

Regulatory Affairs

The Latest Science

Identifying Biomarkers

Innovation Showcase
Classifying the Microbiota
Skin: A New Target for Microbiota Interventions

Innovation Showcase & Young Investigators Award

Developing Live Biotherapeutic Products

Skin: A New Target for Microbiota Interventions

Taxonomic Thunderclouds

Conference Programme





08:00 - 08:40am

Registration Sponsored by Probiotical



08:45 - 09:15am

Key Note: Live Biotherapeutics; Enhancing Health Through Modulating the Human Microbiome

Paul Cotter


Taxonomic Thunderclouds


09:15 - 09:45am

Untangling the Evolutionary Development of the Genus Bifidobacterium by Comparative Genomics

Marco Ventura


09:45 - 10:15am

Deciphering the Diversity of Genus Lactobacillus:

A Taxonomic Tale

Giovanna Felis


10:15 - 10:30am

Therapeutic Potential of Probiotics for Mood: New

Evidence from a Double-blind, Placebo Controlled Study

Marco Pane


Regulatory Affairs Chaired by Colette Shortt


11:15 - 11:45am

The PRI: An Innovative Approach in Absence of Clear Regulatory Framework at the EU Level

Magali Cordaillat-Simmons


11:45am - 12:15pm

Nagoya Protocol: Legal Framework and Practical Consequences

Katia Martin-Lentz


12:15 - 13:00pm

Interactive Session: Internationalisation of Regulatory Issues

for Pharmabiotics: What Needs to be Done?

Moderator: Sin-Hyeog Im

Participants: Colette Shortt, Magali Cordaillat-Simmons



Skin: A New Target for Microbiota Interventions

Chaired by Bernard Pietzold


14:00 - 14:30pm

Skin Microbiota: Interest and Management

Richard Martin


14:30am - 15:00pm

Investigating and Understanding the Role of the Skin Microbiota in Skin Disorders

Holger Brüggemann


15:00 - 15:30pm

'Bugs as Drugs' for the Skin: Novel Microbiome-based Strategies for Skin Diseases

Travis Witfil


The Latest Science


16:45 - 17:15pm

How to Develop Probiotics as Immune-modulatory Pharmabiotics

Sin-Hyeog Im


17:15 - 17:45pm

Title & Speaker to be confirmed


17:45 - 18:00pm

Biofortis Presentation and Introduction of Young Investigator Awards Finalists


18:00 - 18:30pm

Young Investigator Awards Finalists' Presentations


Bioinformatic Challenges in Microbiome Analyses

by Bruno Pot


16:15 - 16:45pm

How Can You Trust your Analysis Results from Targeted Metagenomics Studies?

Ségolène Caboche


16:45 - 17:15pm

The Challenges in Performing Metagenomic Studies to Understand the Role of Gut Microbiome in Diseases

Manimozhiyan Arumugam


Innovation Showcase Chaired by Richard Ellis


14:30 - 15:00pm

Pioneering Microbiome Innovations

David Berry


15:00 - 15:05pm

Start-Up 1


15:05 - 15:10pm

Start-Up 2


15:10 - 15:15pm

Start-Up 3


15:15 - 15:20pm

Start-Up 4


15:20 - 15:30pm

Start-Up 5


Identifying Biomarkers Chaired by Adrien Nivoliez


11:15 - 11:45am

Biomarkers in Diabetes

(Title & Speaker TBC)


11:45am - 12:15pm

Biomarkers in Osteoarthritis: Where are we?

Where are we Going?

Yves Henrotin


12:15 - 12:45pm

Emerging Biomarkers in Oncology Related to Microbiome Disruption. Where are we Now and Where do we Need to go?

Jack Gilbert & John Slattery


Developing Live Biotherapeutic Products


09:00 - 09:30am

Personalized Pharmabiotics for Correction of Nosology and Individual Specific Microbiota and Immune Response

Nadya Boyko


09:30 - 10:00am

Ultra-high Resolution Microbiomics

Pernille Myers


10:00 - 10:30am

A Systematic Review with Meta-analysis of a Pharmabiotic Composition for the Management of Ulcerative Colitis Remission in a Chinese Population

Thomas Tompkins


09:00 - 08:40am

Key Note II: The Microbiome: What Pharma Wants, What Pharma Thinks?

Marie Lindner


08:40 - 08:45am

Welcome Address by Bruno Pot


10:30 - 11:15am

Coffee Break Sponsored by Zymo Research



13:00 - 14:00pm

Lunch Sponsored by Winclove



15:45 - 16:45pm

Coffee Break Sponsored by Zymo Research



15:30 - 16:15pm

Coffee Break



10:30 - 11:15am

Coffee Sponsored by Lallemand



08:00 - 08:30am

Registration Sponsored by Probiotical



12:45 - 13:00pm

From Dysbiosis to Cancer: Microbiome Research in

Oncology and its Impact for Health and Therapy

Adolf Heschl


15:30 - 15:45pm

Standardising Microbiomics - Removing Bias

in Collection, Purification and Analyses

Sarah Hemmasi


18:15 - 19:15pm

YIA Awards Ceremony & Cocktail Reception

Sponsored by PRI



17:15 - 17:45pm

Panel Discussion: How to Overcome the Difficulties

Relating to the Inter-Analysis Variability



13:30 - 14:30pm

Lunch Sponsored by Winclove


Speakers & Chairs

David Berry

General Partner

Flagship Pioneering

Manimozhiyan Arumugam Associate Professor

Novo Nordisk Foundation

Travis Whitfill

Co-Founder & CSO

Azitra Inc

Sin-Hyeog Im



John Slattery

Director of Research and Innovation

Aces Health Inc.

Marie Lindner

Global Head, Strategic Partnerships Team


Yolanda Sanz




Holger Brüggemann Associate Professor

AARHUS University

Adrien Nivoliez


Biose Industrie

Giovanna Felis

Associate Professor University of Verona

Paul Cotter

Prinicpal Investigator

APC Microbiome Institute

Yves Henrotin


University of Liège

Pernille Myers

Bioinformatics Specialist Clinical Microbiomics

Magali Cordaillat-Simmons Executive Scientist


Bruno Pot



Sarah Hemmasi

Research Associate

Zymo Research

Katia Merten-Lentz


Keller and Heckman LLP

Marco Ventura


University of Parma

Colette Shortt

Johnson & Johnson

Richard Martin


Mercurialis Biotech

Ségolène Caboche

Bioinformatics Researcher

Université de Lille

Nadiya Boyko


Uzhhorod National University

Stephanie Ferreira

Innovation Manager GenoScreen

Richard Ellis

Business Development


Marco Pane

Product Specialist


Adolf Heschl


University of Graz

Call for Abstracts

Pharmabiotics 2018 focuses on the science and business of new research and technologies for treating diseases and sustaining health via the Human Microbiota.


If you are an expert in the field, either from Academia or Industry and have research to present (verbal or poster), we would like to hear from you!


Please complete the form on the right, following the specified guidelines:



Abstract Submission Guidelines


General Criteria


Only abstracts on recent original research related to the influence of the microbiota, as well as the analytical tools, therapeutic potential, mechanisms of action, pre-clinical and clinical efficacy in the treatment or prevention of pathologies will be accepted.



Abstract Format


Language English


Length Up to 300 words are accepted. Abstracts cannot include tables or figures.


Only standardized abbreviations will be allowed. Any abbreviation should be explained in brackets the first time it appears in the text.


Selection will be carried out on the basis of overall quality of the abstract and special interest by the scientific committee. Abstract acceptance or rejection will be notified by e-mail along with presentation criteria and other details.


The scientific committee reserves the rights to reject proposals that are beyond the scope of the conference.


Submissions imply the intent of at least one author to register, attend the conference and present the study. The author has to be registered before January 31st 2018.




Fill out my online form.
HTML Forms powered by Wufoo.